GPC Biotech’s mission was to discover and develop novel anti-cancer drugs. The founding team raised two private financing rounds in 1997 and 1999, acquired a Boston-based drug discovery company, took GPC public in 2000 and listed GPC on Nasdaq in 2004. It developed an anti-cancer drug through clinical phase 3 and filed for market registration. In 2009, GPC Biotech merged with the US-based company Agennix Inc.
View Top Employees from GPC Biotech AGWebsite | https://www.gpc-biotech.com |
Ticker | NASDAQ:GPCB |
Revenue | $58 million |
Employees | 34 (18 on RocketReach) |
Founded | 1997 |
Phone | (781) 466-4400 |
Fax | (781) 890-9005 |
Technologies |
JavaScript,
HTML,
PHP
+10 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Biopharma, Business Services, Biotechnology, Health Care, Science and Engineering, Therapeutics |
Web Rank | 12 Million |
Keywords | Con Cuanta Frecuencia Hay Que Afeitarse La Cabeza Para Permanecer Calvo, La Ranitidina Afecta La Presion Arterial |
Competitors | Exelixis, Galapagos, Lexicon Pharmaceuticals, Inc., PharmaMar, TopoTarget |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 541713 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies |
Looking for a particular GPC Biotech AG employee's phone or email?
The GPC Biotech AG annual revenue was $58 million in 2024.
Igor Ivanov is the Director, Cell Biology of GPC Biotech AG.
18 people are employed at GPC Biotech AG.
The NAICS codes for GPC Biotech AG are [541, 541713, 54, 54171, 5417].
The SIC codes for GPC Biotech AG are [873, 87].